The Effect of Time Restricted Eating on Glycemic and Proinflammatory Biomarkers Among Prediabetic Obese Jordanian Adults Aged 18-40 Years Old

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorUniversity of Jordan

About this trial

Obesity, a global epidemic, significantly contributes to prediabetes, cardiovascular diseases, and other chronic diseases due to its pro-inflammatory nature. This studyl investigates the effects of time-restricted eating (TRE) with calorie restriction (CR), TRE without CR, and CR without TRE on glycemic control and pro-inflammatory biomarkers among prediabetic obese Jordanian adults aged 18-40 years. The study assesses changes in pro-inflammatory biomarkers (IL-1β, TNF-α, IL-6), insulin resistance (HOMA-IR), and body composition over 12 weeks.

Participants (n=120) will be randomized into four intervention arms: (1) TRE with CR, (2) TRE without CR, (3) CR without TRE, and (4) a control group with no dietary restrictions and no TRE. Biweekly anthropometric assessments will evaluate pro-inflammatory biomarkers and biochemical measures at baseline and the end of the study. The findings will provide insights into the comparative effectiveness of TRE and CR, potentially offering a safe, cost-effective intervention to prevent obesity-induced inflammation, prediabetes, and progression to type 2 diabetes mellitus.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

IR individuals diagnosed with IR by the physicians as indicated by HOMA-IR score

female and male, BMI ≥ 30 to 39.9 kg/m2

age between 18 and 40 years

stable weight for 3 months before the beginning of the study

Disqualifiers

previous weight loss surgery

pregnancy or intent to become pregnant

breastfeeding

chronic diseases

Trial design

Design model

Factorial

Treatments tested in this trial

  • time restricted eating with caloric restriction

    Other intervention

    will be asked to reduce their energy intake by 550 each day. Total energy expenditure will be calculated using the Bioelectrical impedance (BIA); Inbody 120 and multiplied by the physical activity factor and reduced by 550 kilo calories for each participant. The acceptable macronutrient distribution range (AMDR) will be 45-60% carbohydrates, 15-25% protein, and 20-30% fat of the total caloric value and fasted from 18:00 to 8:00 daily (a 14-h fast) in the 12-weeks intervention

  • time restricted eating without caloric restriction

    Other intervention

    will be asked to maintain their normal diet to the acceptable normal distribution ranges and fast from 8:00 to 18:00. They do not need to restrict caloric intake during the feeding window

  • Caloric restriction without Time restricted eating

    Other intervention

    will be asked to reduce their energy intake by 550 each day. Total energy expenditure will be calculated using the Bioelectrical impedance (BIA); Inbody 120 and multiplied by the physical activity factor and reduced by 550 kilo calories for each participant. The acceptable macronutrient distribution range (AMDR) will be 45-60% carbohydrates, 15-25% protein, and 20-30% fat of the total caloric value

  • No time restricted eating - Normal diet

    Other intervention

    will be asked to maintain their normal diet as the second intervention arm without time restricted eating throughout the trial

Treatment groups

120 Participants
are divided into 4 treatment groups
Group A: 10-h Time restricted eating with caloric restrictionExperimental treatment 1 intervention
Group B: 10-h time restricted eating without caloric restrictionActive comparator 1 intervention
Group C: caloric restriction without time restricted eatingActive comparator 1 intervention
Group D: No time restricted eating - normal dietActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Serum of TNF-α, IL-1β and IL-6

Will be measured using ELISA before and after dietary intervention to assess the impact of time restricted eating on these proinflammatory biomarkers in participants diagnosed with Insulin resistance

Time frame
baseline and after 12 weeks of intervention

Secondary outcomes

1

Homa-IR

Homa-IR will be assessed using the homeostasis model assessment (HOMA) method, which involves applying the formula \[fasting glucose (mg/dL) \* fasting insulin (mU/mL)/ 405\] to evaluate the changes in insulin resistance over 12 weeks of intervention

Time frame
baseline and after 12 weeks of intervention
2

Lipid profile (LDL, HDL, TG, and cholesterol)

will be analyzed at based line and post intervention to determine the impact of dietary modification on lipid profile

Time frame
baseline and after 12 weeks of intervention
3

body weight

in kilograms (Using inbody 120 )

Time frame
baseline and every 2 weeks until 12 weeks of intervention
4

Dietary intake using food records

Time frame
week4, week 8, and week 12 week

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: